Article Text

Download PDFPDF
Poorly performing point-of-care tests for chlamydia: what can be done?
  1. Sue Skidmore
  1. Correspondence to Dr Sue Skidmore, Department of Microbiology, Princess Royal Hospital, Telford TF1 6TF, UK; sue.skidmore{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

van Dommelen et al1 (see page 355)convincingly show the problems associated with some Chlamydia trachomatis point-of-care (POC) tests that have concerned many of us for some time.2 They have looked at three commercially available Conformitée Européene (CE)-marked kits and compared the results with the current ‘gold standard’, a nucleic acid amplification test (NAAT). Testing was carried out in what might be regarded as optimal conditions by healthcare professionals and even so the authors describe ‘alarmingly poor performance’, particularly in terms of sensitivity and positive predictive value. The results obtained would have led to infections being missed and to those with false-positive results being treated unnecessarily. With growing awareness of the development of antimicrobial …

View Full Text


  • Linked articles: 042598.

  • Competing interests None declared.

  • Provenance and peer review Commissioned; not externally peer reviewed.

Linked Articles

  • Basic science
    Laura van Dommelen Frank H van Tiel Sander Ouburg Elfi E H G Brouwers Peter H W Terporten Paul H M Savelkoul Servaas A Morré Cathrien A Bruggeman Christian J P A Hoebe
  • Whistlestop tour
    Jackie A Cassell